Friday, July 31, 2026

From Hype to Halt: Xiaomi’s EV on Hold After Deadly SU7 Crash and Fire

Xiaomi delays the YU7 electric SUV launch after a fatal fire incident involving the SU7 sedan raised safety concerns.

Olympic Selfie: North and South Korean Athletes Celebrate Together

IOC highlighted a photo taken at the medal ceremony showing North and South Korean athletes together at the podium.

Samsung and Google’s ‘Project Infinity’ XR Headset Leaks With Big Specs

Samsung and Google unveil Project Infinity XR headset with advanced features, including Snapdragon XR2+ chipset and AI integration.

Tag: biotechnology

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

Daejeon University launched the 2025 Winter BioRG Training Program for biopharmaceuticals, featuring industry experts and hands-on sessions.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Xenovax PCM4: The Next-Gen Vaccine Transforming Pig Farming in Asia – Find Out How!

CARESIDE's swine vaccine technology certified as New Excellent Technology, enhancing protection and reducing farmer labor demands.

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

BIO USA 2025: Korea’s Pavilion Grows, Deals Multiply, and New Biotech Faces Emerge

BIO USA 2025 showcased South Korea's biotech presence, with significant participation from firms like Samsung Biologics and Lotte Biologics.

Samsung Launches New Mini-Organ Tech to Speed Up Cancer Drug Testing

Samsung Biologics launches Samsung Organoids for drug screening, focusing on anticancer candidates to enhance precision and reduce costs.

Breakthrough Tech Tailors Gene Editing to Your DNA

Researchers at Pusan National University developed a tool for personalized gene editing, predicting side effects based on DNA variations.

David Sinclair and Irina Conboy Lead Breakthroughs in Age-Reversing Technology

Leading scientists are advancing aging reversal technologies, focusing on gene reprogramming and plasma dilution for potential rejuvenation.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.